Skip to main content
Erschienen in: Clinical Reviews in Allergy & Immunology 1/2019

22.03.2019

Allergic Comorbidity in Eosinophilic Esophagitis: Mechanistic Relevance and Clinical Implications

verfasst von: Peter Capucilli, David A. Hill

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Allergic eosinophilic esophagitis (EoE) is a chronic, allergen-mediated inflammatory disease of the esophagus, and the most common cause of prolonged dysphagia in children and young adults in the developed world. While initially undistinguished from gastroesophageal reflux disease-associated esophageal eosinophilia, EoE is now recognized as a clinically distinct entity that shares fundamental inflammatory features of other allergic conditions and is similarly increasing in incidence and prevalence. The clinical and epidemiologic associations between EoE and other allergic manifestations are well established. In addition to exaggerated rates of atopic dermatitis, IgE-mediated food allergy, asthma, and allergic rhinitis in EoE patients, each of these allergic manifestations imparts individual and cumulative risk for subsequent EoE diagnosis. As such, EoE may be a member of the “allergic march”—the natural history of allergic manifestations during childhood. Several determinants likely contribute to the relationship between these conditions, including shared genetic, environmental, and immunologic factors. Herein, we present a comprehensive review of allergic comorbidity in EoE. We discuss areas of the genome associated with both EoE and other allergic diseases, including the well-studied variants encoding thymic stromal lymphopoietin and calpain 14, among other “atopic” regions. We summarize ways that environmental factors (such as microbiome-altering pressures and aeroallergen exposure) may predispose to multiple allergic conditions including EoE. Finally, we touch on some fundamental features of type 2 inflammation, and the resulting implications for the development of multiple allergic manifestations. We conclude with an analysis of the “type 2” biologics, and how mechanistic similarities between EoE and the other allergic manifestations have important implications for screening and treatment of the allergic patient.
Literatur
1.
Zurück zum Zitat Cianferoni A, Spergel J (2016) Eosinophilic esophagitis: a comprehensive review. Clin Rev Allergy Immunol 50(2):159–174CrossRefPubMed Cianferoni A, Spergel J (2016) Eosinophilic esophagitis: a comprehensive review. Clin Rev Allergy Immunol 50(2):159–174CrossRefPubMed
2.
Zurück zum Zitat Hill DA, Spergel JM (2016) The immunologic mechanisms of eosinophilic esophagitis. Curr Allergy Asthma Rep 16(2):1–15CrossRef Hill DA, Spergel JM (2016) The immunologic mechanisms of eosinophilic esophagitis. Curr Allergy Asthma Rep 16(2):1–15CrossRef
3.
Zurück zum Zitat Breier-Mackie S (2007) Cultural competence and patient advocacy: the new challenge for nurses. Gastroenterol Nurs 30(2):120–122CrossRefPubMed Breier-Mackie S (2007) Cultural competence and patient advocacy: the new challenge for nurses. Gastroenterol Nurs 30(2):120–122CrossRefPubMed
5.
Zurück zum Zitat Walsh SV, Antonioli DA, Goldman H, Fox VL, Bousvaros A, Leichtner AM et al (1999) Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 23(4):390–396CrossRefPubMed Walsh SV, Antonioli DA, Goldman H, Fox VL, Bousvaros A, Leichtner AM et al (1999) Allergic esophagitis in children: a clinicopathological entity. Am J Surg Pathol 23(4):390–396CrossRefPubMed
6.
Zurück zum Zitat Attwood SEA, Smyrk TC, Demeester TR, Jones JB (1993) Esophageal eosinophilia with dysphagia—a distinct clinicopathologic syndrome. Dig Dis Sci 38(1):109–116CrossRefPubMed Attwood SEA, Smyrk TC, Demeester TR, Jones JB (1993) Esophageal eosinophilia with dysphagia—a distinct clinicopathologic syndrome. Dig Dis Sci 38(1):109–116CrossRefPubMed
7.
Zurück zum Zitat Straumann A, Bauer M, Fischer B, Blaser K, Simon HU (2001) Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response. J Allergy Clin Immunol 108(6):954–961CrossRefPubMed Straumann A, Bauer M, Fischer B, Blaser K, Simon HU (2001) Idiopathic eosinophilic esophagitis is associated with a TH2-type allergic inflammatory response. J Allergy Clin Immunol 108(6):954–961CrossRefPubMed
8.
Zurück zum Zitat Arias A, Pérez-Martínez I, Tenías JM, Lucendo AJ (2016) Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther 43(1):3–15CrossRefPubMed Arias A, Pérez-Martínez I, Tenías JM, Lucendo AJ (2016) Systematic review with meta-analysis: the incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies. Aliment Pharmacol Ther 43(1):3–15CrossRefPubMed
9.
Zurück zum Zitat Dellon ES (2014) Epidemiology of eosinophilic esophagitis. Gastroenterol Clin N Am 43(2):201–218CrossRef Dellon ES (2014) Epidemiology of eosinophilic esophagitis. Gastroenterol Clin N Am 43(2):201–218CrossRef
10.
Zurück zum Zitat Dellon ES, Hirano I (2018) Epidemiology and Natural History of Eosinophilic Esophagitis. Gastroenterology 154(2):319–332.e3CrossRefPubMed Dellon ES, Hirano I (2018) Epidemiology and Natural History of Eosinophilic Esophagitis. Gastroenterology 154(2):319–332.e3CrossRefPubMed
11.
Zurück zum Zitat Merves J, Muir A, Modayur Chandramouleeswaran P, Cianferoni A, Wang M-L, Spergel JM (2014) Eosinophilic esophagitis. Ann Allergy Asthma Immunol 112(5):397–403CrossRefPubMedPubMedCentral Merves J, Muir A, Modayur Chandramouleeswaran P, Cianferoni A, Wang M-L, Spergel JM (2014) Eosinophilic esophagitis. Ann Allergy Asthma Immunol 112(5):397–403CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Molina-Infante J, Lucendo AJ (2018) Dietary therapy for eosinophilic esophagitis. J Allergy Clin Immunol 142(1):41–47CrossRefPubMed Molina-Infante J, Lucendo AJ (2018) Dietary therapy for eosinophilic esophagitis. J Allergy Clin Immunol 142(1):41–47CrossRefPubMed
13.
Zurück zum Zitat Arias Á, González-Cervera J, Tenias JM, Lucendo AJ (2014) Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 146(7):1639–1648CrossRefPubMed Arias Á, González-Cervera J, Tenias JM, Lucendo AJ (2014) Efficacy of dietary interventions for inducing histologic remission in patients with eosinophilic esophagitis: a systematic review and meta-analysis. Gastroenterology. 146(7):1639–1648CrossRefPubMed
14.
Zurück zum Zitat Noti M, Wojno EDT, Kim BS, Siracusa MC, Giacomin PR, Nair MG et al (2013) Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med 19(8):1005–1013CrossRefPubMedPubMedCentral Noti M, Wojno EDT, Kim BS, Siracusa MC, Giacomin PR, Nair MG et al (2013) Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med 19(8):1005–1013CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Spergel JM, Brown-Whitehorn TF, Cianferoni A, Shuker M, Wang ML, Verma R et al (2012) Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol 130(2):461–7.e5CrossRefPubMed Spergel JM, Brown-Whitehorn TF, Cianferoni A, Shuker M, Wang ML, Verma R et al (2012) Identification of causative foods in children with eosinophilic esophagitis treated with an elimination diet. J Allergy Clin Immunol 130(2):461–7.e5CrossRefPubMed
16.
Zurück zum Zitat Kagalwalla AF, Shah A, Li BUK, Sentongo TA, Ritz S, Manuel-Rubio M et al (2011) Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet. J Pediatr Gastroenterol Nutr 53(2):145–149CrossRefPubMed Kagalwalla AF, Shah A, Li BUK, Sentongo TA, Ritz S, Manuel-Rubio M et al (2011) Identification of specific foods responsible for inflammation in children with eosinophilic esophagitis successfully treated with empiric elimination diet. J Pediatr Gastroenterol Nutr 53(2):145–149CrossRefPubMed
17.
Zurück zum Zitat Dohil R, Newbury R, Fox L, Bastian J, Aceves S (2010) Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 139(2):418–429CrossRefPubMed Dohil R, Newbury R, Fox L, Bastian J, Aceves S (2010) Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 139(2):418–429CrossRefPubMed
18.
Zurück zum Zitat Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H et al (2010) Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 139(5):1526–1537CrossRefPubMed Straumann A, Conus S, Degen L, Felder S, Kummer M, Engel H et al (2010) Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology. 139(5):1526–1537CrossRefPubMed
19.
Zurück zum Zitat Debrosse CW, Franciosi JP, King EC, Buckmeier Butz BK, Greenberg AB, Collins MH et al (2011) Long-term outcomes in pediatric-onset esophageal eosinophilia. J Allergy Clin Immunol 128(1):132–138CrossRefPubMedPubMedCentral Debrosse CW, Franciosi JP, King EC, Buckmeier Butz BK, Greenberg AB, Collins MH et al (2011) Long-term outcomes in pediatric-onset esophageal eosinophilia. J Allergy Clin Immunol 128(1):132–138CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Hirano I, Aceves SS (2014) Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. Gastroenterol Clin N Am 43(2):297–316CrossRef Hirano I, Aceves SS (2014) Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis. Gastroenterol Clin N Am 43(2):297–316CrossRef
21.
Zurück zum Zitat González-Cervera J, Arias Á, Redondo-González O, Cano-Mollinedo MM, Terreehorst I, Lucendo AJ (2017) Association between atopic manifestations and eosinophilic esophagitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol 118(5):582–590.e2CrossRefPubMed González-Cervera J, Arias Á, Redondo-González O, Cano-Mollinedo MM, Terreehorst I, Lucendo AJ (2017) Association between atopic manifestations and eosinophilic esophagitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol 118(5):582–590.e2CrossRefPubMed
22.
23.
Zurück zum Zitat Simon D, Marti H, Heer P, Simon HU, Braathen LR, Straumann A (2005) Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases [3]. J Allergy Clin Immunol 115(5):1090–1092CrossRefPubMed Simon D, Marti H, Heer P, Simon HU, Braathen LR, Straumann A (2005) Eosinophilic esophagitis is frequently associated with IgE-mediated allergic airway diseases [3]. J Allergy Clin Immunol 115(5):1090–1092CrossRefPubMed
24.
Zurück zum Zitat Sugnanam KKN, Collins JT, Smith PK, Connor F, Lewindon P, Cleghorn G et al (2007) Dichotomy of food and inhalant allergen sensitization in eosinophilic esophagitis. Allergy 62(11):1257–1260CrossRefPubMed Sugnanam KKN, Collins JT, Smith PK, Connor F, Lewindon P, Cleghorn G et al (2007) Dichotomy of food and inhalant allergen sensitization in eosinophilic esophagitis. Allergy 62(11):1257–1260CrossRefPubMed
25.
Zurück zum Zitat Mahdavinia M, Bishehsari F, Hayat W, Elhassan A, Tobin MC, Ditto AM (2017) Association of eosinophilic esophagitis and food pollen allergy syndrome. Ann Allergy Asthma Immunol 118(1):116–117CrossRefPubMed Mahdavinia M, Bishehsari F, Hayat W, Elhassan A, Tobin MC, Ditto AM (2017) Association of eosinophilic esophagitis and food pollen allergy syndrome. Ann Allergy Asthma Immunol 118(1):116–117CrossRefPubMed
26.
Zurück zum Zitat Letner D, Farris A, Khalili H, Garber J (2018) Pollen-food allergy syndrome is a common allergic comorbidity in adults with eosinophilic esophagitis. Dis Esophagus 31(2):1–8CrossRef Letner D, Farris A, Khalili H, Garber J (2018) Pollen-food allergy syndrome is a common allergic comorbidity in adults with eosinophilic esophagitis. Dis Esophagus 31(2):1–8CrossRef
27.
Zurück zum Zitat Hill DA, Grundmeier RW, Ramos M, Spergel JM (2018) Eosinophilic esophagitis is a late manifestation of the allergic march. J Allergy Clin Immunol Pract 6(5):1528–1533CrossRefPubMedPubMedCentral Hill DA, Grundmeier RW, Ramos M, Spergel JM (2018) Eosinophilic esophagitis is a late manifestation of the allergic march. J Allergy Clin Immunol Pract 6(5):1528–1533CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Hill DA, Dudley JW, Spergel JM (2017) The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy. J Allergy Clin Immunol Pract 5(2):369–375CrossRefPubMed Hill DA, Dudley JW, Spergel JM (2017) The prevalence of eosinophilic esophagitis in pediatric patients with IgE-mediated food allergy. J Allergy Clin Immunol Pract 5(2):369–375CrossRefPubMed
29.
Zurück zum Zitat Lin SK, Sabharwal G, Ghaffari G (2015) A review of the evidence linking eosinophilic esophagitis and food allergy. Allergy Asthma Proc 36(1):26–33CrossRefPubMed Lin SK, Sabharwal G, Ghaffari G (2015) A review of the evidence linking eosinophilic esophagitis and food allergy. Allergy Asthma Proc 36(1):26–33CrossRefPubMed
30.
Zurück zum Zitat Ram G, Lee J, Ott M, Brown-Whitehorn TF, Cianferoni A, Shuker M et al (2015) Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis. Ann Allergy Asthma Immunol 115(3):224–228CrossRefPubMed Ram G, Lee J, Ott M, Brown-Whitehorn TF, Cianferoni A, Shuker M et al (2015) Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis. Ann Allergy Asthma Immunol 115(3):224–228CrossRefPubMed
31.
Zurück zum Zitat Hill DA, Spergel JM (2018) Is eosinophilic esophagitis a member of the atopic march? Ann Allergy Asthma Immunol 120(2):113–114CrossRefPubMed Hill DA, Spergel JM (2018) Is eosinophilic esophagitis a member of the atopic march? Ann Allergy Asthma Immunol 120(2):113–114CrossRefPubMed
32.
Zurück zum Zitat Atkins D, Furuta GT, Liacouras CA, Spergel JM (2017) Eosinophilic esophagitis phenotypes: ready for prime time? Pediatr Allergy Immunol 28(4):312–319CrossRefPubMedPubMedCentral Atkins D, Furuta GT, Liacouras CA, Spergel JM (2017) Eosinophilic esophagitis phenotypes: ready for prime time? Pediatr Allergy Immunol 28(4):312–319CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Shoda T, Wen T, Aceves SS, Abonia JP, Atkins D, Bonis PA et al (2018) Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study. Lancet Gastroenterol Hepatol 3(7):477–488CrossRefPubMedPubMedCentral Shoda T, Wen T, Aceves SS, Abonia JP, Atkins D, Bonis PA et al (2018) Eosinophilic oesophagitis endotype classification by molecular, clinical, and histopathological analyses: a cross-sectional study. Lancet Gastroenterol Hepatol 3(7):477–488CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Sicherer SH, Sampson HA (2007) Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol 120(3):491–503CrossRefPubMed Sicherer SH, Sampson HA (2007) Peanut allergy: emerging concepts and approaches for an apparent epidemic. J Allergy Clin Immunol 120(3):491–503CrossRefPubMed
35.
Zurück zum Zitat Sicherer SH, Muñoz-Furlong A, Burks AW, Sampson HA (1999) Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey. J Allergy Clin Immunol 103(4):559–562CrossRefPubMed Sicherer SH, Muñoz-Furlong A, Burks AW, Sampson HA (1999) Prevalence of peanut and tree nut allergy in the US determined by a random digit dial telephone survey. J Allergy Clin Immunol 103(4):559–562CrossRefPubMed
36.
Zurück zum Zitat Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker M, Verma R et al (2009) 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 48(1):30–36CrossRefPubMed Spergel JM, Brown-Whitehorn TF, Beausoleil JL, Franciosi J, Shuker M, Verma R et al (2009) 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr 48(1):30–36CrossRefPubMed
37.
Zurück zum Zitat Straumann A, Simon HU (2005) Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 115(2):418–419CrossRefPubMed Straumann A, Simon HU (2005) Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol 115(2):418–419CrossRefPubMed
38.
Zurück zum Zitat Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA et al (2011) Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 128(1):3–20CrossRefPubMed Liacouras CA, Furuta GT, Hirano I, Atkins D, Attwood SE, Bonis PA et al (2011) Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol 128(1):3–20CrossRefPubMed
39.
Zurück zum Zitat Benninger MS, Strohl M, Holy CE, Hanick AL, Bryson PC (2017) Prevalence of atopic disease in patients with eosinophilic esophagitis. Int Forum Allergy Rhinol 7(8):757–762CrossRefPubMed Benninger MS, Strohl M, Holy CE, Hanick AL, Bryson PC (2017) Prevalence of atopic disease in patients with eosinophilic esophagitis. Int Forum Allergy Rhinol 7(8):757–762CrossRefPubMed
40.
Zurück zum Zitat Guajardo JR, Plotnick LM, Fende JM, Collins MH, Putnam PE, Rothenberg ME (2002) Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry. J Pediatr 141(4):576–581CrossRefPubMed Guajardo JR, Plotnick LM, Fende JM, Collins MH, Putnam PE, Rothenberg ME (2002) Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry. J Pediatr 141(4):576–581CrossRefPubMed
41.
Zurück zum Zitat Jyonouchi S, Brown-Whitehorn TA, Spergel JM (2009) Association of eosinophilic gastrointestinal disorders with other atopic disorders. Immunol Allergy Clin N Am 29(1):85–97CrossRef Jyonouchi S, Brown-Whitehorn TA, Spergel JM (2009) Association of eosinophilic gastrointestinal disorders with other atopic disorders. Immunol Allergy Clin N Am 29(1):85–97CrossRef
42.
Zurück zum Zitat Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E et al (2005) Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 3(12):1198–1206CrossRefPubMed Liacouras CA, Spergel JM, Ruchelli E, Verma R, Mascarenhas M, Semeao E et al (2005) Eosinophilic esophagitis: a 10-year experience in 381 children. Clin Gastroenterol Hepatol 3(12):1198–1206CrossRefPubMed
43.
Zurück zum Zitat Assa’ad AH, Putnam PE, Collins MH, Akers RM, Jameson SC, Kirby CL et al (2007) Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol 119(3):731–738CrossRefPubMed Assa’ad AH, Putnam PE, Collins MH, Akers RM, Jameson SC, Kirby CL et al (2007) Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol 119(3):731–738CrossRefPubMed
44.
Zurück zum Zitat Baumert JL (2013) Detecting and measuring allergens in food. Risk Manag Food Allergy:215–226 Baumert JL (2013) Detecting and measuring allergens in food. Risk Manag Food Allergy:215–226
45.
Zurück zum Zitat Dellon ES, Rusin S, Gebhart JH, Covey S, Speck O, Woodward K et al (2015) A clinical prediction tool identifies cases of eosinophilic esophagitis without endoscopic biopsy: a prospective study. Am J Gastroenterol 110(9):1347–1354CrossRefPubMedPubMedCentral Dellon ES, Rusin S, Gebhart JH, Covey S, Speck O, Woodward K et al (2015) A clinical prediction tool identifies cases of eosinophilic esophagitis without endoscopic biopsy: a prospective study. Am J Gastroenterol 110(9):1347–1354CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Leung AJT, Persad S, Slae M, Abdelradi A, Kluthe C, Shirton L et al (2015) Intestinal and gastric permeability in children with eosinophilic esophagitis and reflux esophagitis. J Pediatr Gastroenterol Nutr 60(2):236–239CrossRefPubMed Leung AJT, Persad S, Slae M, Abdelradi A, Kluthe C, Shirton L et al (2015) Intestinal and gastric permeability in children with eosinophilic esophagitis and reflux esophagitis. J Pediatr Gastroenterol Nutr 60(2):236–239CrossRefPubMed
47.
Zurück zum Zitat Peterson K, Fang JCFR (2015) Familial risk of eosinophilic gastrointestinal disorders (EGID) and atopy in eosinophilic esophagitis (EoE). Gastroenterology 148(Se414) Peterson K, Fang JCFR (2015) Familial risk of eosinophilic gastrointestinal disorders (EGID) and atopy in eosinophilic esophagitis (EoE). Gastroenterology 148(Se414)
48.
Zurück zum Zitat Duffey H, Peterson KFR (2016) Population-based study suggests strong genetic association between eosinophilic esophagitis and asthma. J Allergy Clin Immunol 137(AB400) Duffey H, Peterson KFR (2016) Population-based study suggests strong genetic association between eosinophilic esophagitis and asthma. J Allergy Clin Immunol 137(AB400)
49.
Zurück zum Zitat Capucilli P, Cianferoni A, Grundmeier RW, Spergel JM (2018) Comparison of comorbid diagnoses in children with and without eosinophilic esophagitis in a large population. Ann Allergy Asthma Immunol 121(6):711–716CrossRefPubMed Capucilli P, Cianferoni A, Grundmeier RW, Spergel JM (2018) Comparison of comorbid diagnoses in children with and without eosinophilic esophagitis in a large population. Ann Allergy Asthma Immunol 121(6):711–716CrossRefPubMed
50.
Zurück zum Zitat Chehade M, Jones SM, Pesek RD, Burks AW, Vickery BP, Wood RA et al (2018) Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the consortium for food allergy research. J Allergy Clin Immunol Pract 6(5):1534–1544.e5CrossRefPubMedPubMedCentral Chehade M, Jones SM, Pesek RD, Burks AW, Vickery BP, Wood RA et al (2018) Phenotypic characterization of eosinophilic esophagitis in a large multicenter patient population from the consortium for food allergy research. J Allergy Clin Immunol Pract 6(5):1534–1544.e5CrossRefPubMedPubMedCentral
51.
Zurück zum Zitat Leigh LY, Spergel JM (2019) An in-depth characterization of a large cohort of adult patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol 122(1):65–72.e.1CrossRefPubMed Leigh LY, Spergel JM (2019) An in-depth characterization of a large cohort of adult patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol 122(1):65–72.e.1CrossRefPubMed
53.
Zurück zum Zitat Sherrill JD, Rothenberg ME (2014) Genetic and epigenetic underpinnings of eosinophilic esophagitis. Gastroenterol Clin N Am 43(2):269–280CrossRef Sherrill JD, Rothenberg ME (2014) Genetic and epigenetic underpinnings of eosinophilic esophagitis. Gastroenterol Clin N Am 43(2):269–280CrossRef
54.
Zurück zum Zitat Alexander ES, Martin LJ, Collins MH, Kottyan LC, Sucharew H, He H et al (2014) Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol 134(5):1084–1092.e1CrossRefPubMedPubMedCentral Alexander ES, Martin LJ, Collins MH, Kottyan LC, Sucharew H, He H et al (2014) Twin and family studies reveal strong environmental and weaker genetic cues explaining heritability of eosinophilic esophagitis. J Allergy Clin Immunol 134(5):1084–1092.e1CrossRefPubMedPubMedCentral
55.
Zurück zum Zitat Sleiman PMA, Wang ML, Cianferoni A, Aceves S, Gonsalves N, Nadeau K et al (2014) GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun 5 Sleiman PMA, Wang ML, Cianferoni A, Aceves S, Gonsalves N, Nadeau K et al (2014) GWAS identifies four novel eosinophilic esophagitis loci. Nat Commun 5
56.
Zurück zum Zitat Ferreira MAR, Matheson MC, Tang CS, Granell R, Ang W, Hui J et al (2014) Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype. J Allergy Clin Immunol 133(6):1564–1571CrossRefPubMed Ferreira MAR, Matheson MC, Tang CS, Granell R, Ang W, Hui J et al (2014) Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype. J Allergy Clin Immunol 133(6):1564–1571CrossRefPubMed
57.
Zurück zum Zitat Weidinger S, Willis-Owen SAG, Kamatani Y, Baurecht H, Morar N, Liang L et al (2013) A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet 22(23):4841–4856CrossRefPubMedPubMedCentral Weidinger S, Willis-Owen SAG, Kamatani Y, Baurecht H, Morar N, Liang L et al (2013) A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet 22(23):4841–4856CrossRefPubMedPubMedCentral
58.
Zurück zum Zitat Hinds DA, McMahon G, Kiefer AK, Do CB, Eriksson N, Evans DM et al (2013) A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat Genet 45(8):907–911CrossRefPubMedPubMedCentral Hinds DA, McMahon G, Kiefer AK, Do CB, Eriksson N, Evans DM et al (2013) A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat Genet 45(8):907–911CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat Rothenberg ME, Spergel JM, Sherrill JD, Annaiah K, Martin LJ, Cianferoni A et al (2010) Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 42(4):289–291CrossRefPubMedPubMedCentral Rothenberg ME, Spergel JM, Sherrill JD, Annaiah K, Martin LJ, Cianferoni A et al (2010) Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet 42(4):289–291CrossRefPubMedPubMedCentral
60.
Zurück zum Zitat Sherrill JD, Gao PS, Stucke EM, Blanchard C, Collins MH, Putnam PE et al (2010) Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol 126(1):160–165.e3CrossRefPubMedPubMedCentral Sherrill JD, Gao PS, Stucke EM, Blanchard C, Collins MH, Putnam PE et al (2010) Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol 126(1):160–165.e3CrossRefPubMedPubMedCentral
61.
Zurück zum Zitat Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B et al (2002) Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol 3(7):673–680CrossRefPubMed Soumelis V, Reche PA, Kanzler H, Yuan W, Edward G, Homey B et al (2002) Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol 3(7):673–680CrossRefPubMed
62.
Zurück zum Zitat Li M, Hener P, Zhang Z, Ganti KP, Metzger DCP (2009) Induction of thymic stromal lymphopoietin expression in keratinocytes is necessary for generating an atopic dermatitis upon application of the active vitamin D3 analogue MC903 on mouse skin. J Invest Dermatol 129(2):498–502CrossRefPubMed Li M, Hener P, Zhang Z, Ganti KP, Metzger DCP (2009) Induction of thymic stromal lymphopoietin expression in keratinocytes is necessary for generating an atopic dermatitis upon application of the active vitamin D3 analogue MC903 on mouse skin. J Invest Dermatol 129(2):498–502CrossRefPubMed
63.
Zurück zum Zitat Kottyan LC, Davis BP, Sherrill JD, Liu K, Rochman M, Kaufman K et al (2014) Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet 46(8):895–900CrossRefPubMedPubMedCentral Kottyan LC, Davis BP, Sherrill JD, Liu K, Rochman M, Kaufman K et al (2014) Genome-wide association analysis of eosinophilic esophagitis provides insight into the tissue specificity of this allergic disease. Nat Genet 46(8):895–900CrossRefPubMedPubMedCentral
64.
Zurück zum Zitat Davis BP, Stucke EM, Khorki ME, Litosh VA, Rymer JK, Rochman M et al (2016) Eosinophilic esophagitis–linked calpain 14 is an IL-13–induced protease that mediates esophageal epithelial barrier impairment. JCI Insight 1(4):e86355CrossRefPubMedPubMedCentral Davis BP, Stucke EM, Khorki ME, Litosh VA, Rymer JK, Rochman M et al (2016) Eosinophilic esophagitis–linked calpain 14 is an IL-13–induced protease that mediates esophageal epithelial barrier impairment. JCI Insight 1(4):e86355CrossRefPubMedPubMedCentral
65.
Zurück zum Zitat Litosh VA, Rochman M, Rymer JK, Porollo A, Kottyan LC, Rothenberg ME (2017) Calpain-14 and its association with eosinophilic esophagitis. J Allergy Clin Immunol 139(6):1762–1771.e7CrossRefPubMedPubMedCentral Litosh VA, Rochman M, Rymer JK, Porollo A, Kottyan LC, Rothenberg ME (2017) Calpain-14 and its association with eosinophilic esophagitis. J Allergy Clin Immunol 139(6):1762–1771.e7CrossRefPubMedPubMedCentral
66.
Zurück zum Zitat Martin LJ, He H, Collins MH, Abonia JP, Biagini Myers JM, Eby M et al (2018) Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci. J Allergy Clin Immunol 141(5):1690–1698CrossRefPubMed Martin LJ, He H, Collins MH, Abonia JP, Biagini Myers JM, Eby M et al (2018) Eosinophilic esophagitis (EoE) genetic susceptibility is mediated by synergistic interactions between EoE-specific and general atopic disease loci. J Allergy Clin Immunol 141(5):1690–1698CrossRefPubMed
67.
Zurück zum Zitat Greisenegger EK, Zimprich F, Zimprich A, Gleiss A, Kopp T (2013) Association of the chromosome 11q13.5 variant with atopic dermatitis in Austrian patients. Eur J Dermatol 23(2):142–145PubMed Greisenegger EK, Zimprich F, Zimprich A, Gleiss A, Kopp T (2013) Association of the chromosome 11q13.5 variant with atopic dermatitis in Austrian patients. Eur J Dermatol 23(2):142–145PubMed
68.
Zurück zum Zitat O’Regan GM, Campbell LE, Cordell HJ, Irvine AD, McLean WHI, Brown SJ (2010) Chromosome 11q13.5 variant associated with childhood eczema: an effect supplementary to filaggrin mutations. J Allergy Clin Immunol 125(1):170–174.e1-2CrossRefPubMedPubMedCentral O’Regan GM, Campbell LE, Cordell HJ, Irvine AD, McLean WHI, Brown SJ (2010) Chromosome 11q13.5 variant associated with childhood eczema: an effect supplementary to filaggrin mutations. J Allergy Clin Immunol 125(1):170–174.e1-2CrossRefPubMedPubMedCentral
69.
Zurück zum Zitat Ferreira MAR, Matheson MC, Duffy DL, Marks GB, Hui J, Le Souëf P et al (2011) Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet. 378(9795):1006–1014CrossRefPubMedPubMedCentral Ferreira MAR, Matheson MC, Duffy DL, Marks GB, Hui J, Le Souëf P et al (2011) Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet. 378(9795):1006–1014CrossRefPubMedPubMedCentral
70.
Zurück zum Zitat Yang SK, Hong M, Zhao W, Jung Y, Baek J, Tayebi N et al (2014) Genome-wide association study of Crohn’s disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut. 63(1):80–87CrossRefPubMed Yang SK, Hong M, Zhao W, Jung Y, Baek J, Tayebi N et al (2014) Genome-wide association study of Crohn’s disease in Koreans revealed three new susceptibility loci and common attributes of genetic susceptibility across ethnic populations. Gut. 63(1):80–87CrossRefPubMed
71.
Zurück zum Zitat Marenholz I, Grosche S, Kalb B, Rüschendorf F, Blümchen K, Schlags R et al (2017) Genome-wide association study identifies the SERPINB gene cluster as a susceptibility locus for food allergy. Nat Commun 8(1):1056CrossRefPubMedPubMedCentral Marenholz I, Grosche S, Kalb B, Rüschendorf F, Blümchen K, Schlags R et al (2017) Genome-wide association study identifies the SERPINB gene cluster as a susceptibility locus for food allergy. Nat Commun 8(1):1056CrossRefPubMedPubMedCentral
72.
Zurück zum Zitat Ellinghaus D, Baurecht H, Esparza-Gordillo J, Rodríguez E, Matanovic A, Marenholz I et al (2013) High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat Genet 45(7):808–812CrossRefPubMedPubMedCentral Ellinghaus D, Baurecht H, Esparza-Gordillo J, Rodríguez E, Matanovic A, Marenholz I et al (2013) High-density genotyping study identifies four new susceptibility loci for atopic dermatitis. Nat Genet 45(7):808–812CrossRefPubMedPubMedCentral
73.
Zurück zum Zitat Kottyan LC, Maddox A, Braxton JR, Stucke EM, Mukkada V, Putnam PE et al (2018) Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis. Genes Immun:1–12 Kottyan LC, Maddox A, Braxton JR, Stucke EM, Mukkada V, Putnam PE et al (2018) Genetic variants at the 16p13 locus confer risk for eosinophilic esophagitis. Genes Immun:1–12
75.
Zurück zum Zitat Consortium THMP (2012) Structure, function and diversity of the healthy human microbiome. Nature. 486(7402):207–214CrossRef Consortium THMP (2012) Structure, function and diversity of the healthy human microbiome. Nature. 486(7402):207–214CrossRef
78.
Zurück zum Zitat Lunjani N, Satitsuksanoa P, Lukasik Z, Sokolowska M, Eiwegger T, O’Mahony L (2018) Recent developments and highlights in mechanisms of allergic diseases: microbiome. Allergy 73(12):2314–2327CrossRefPubMed Lunjani N, Satitsuksanoa P, Lukasik Z, Sokolowska M, Eiwegger T, O’Mahony L (2018) Recent developments and highlights in mechanisms of allergic diseases: microbiome. Allergy 73(12):2314–2327CrossRefPubMed
79.
Zurück zum Zitat Mitselou N, Hallberg J, Stephansson O, Almqvist C, Melén E, Ludvigsson JF (2018) Cesarean delivery, preterm birth, and risk of food allergy: Nationwide Swedish cohort study of more than 1 million children. J Allergy Clin Immunol 142(5):1510–1514CrossRefPubMed Mitselou N, Hallberg J, Stephansson O, Almqvist C, Melén E, Ludvigsson JF (2018) Cesarean delivery, preterm birth, and risk of food allergy: Nationwide Swedish cohort study of more than 1 million children. J Allergy Clin Immunol 142(5):1510–1514CrossRefPubMed
80.
Zurück zum Zitat Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ (2004) Bacterial biota in the human distal esophagus. Proc Natl Acad Sci 101(12):4250–4255CrossRefPubMed Pei Z, Bini EJ, Yang L, Zhou M, Francois F, Blaser MJ (2004) Bacterial biota in the human distal esophagus. Proc Natl Acad Sci 101(12):4250–4255CrossRefPubMed
81.
Zurück zum Zitat Norder Grusell E, Dahlén G, Ruth M, Ny L, Quiding-Järbrink M, Bergquist H et al (2013) Bacterial flora of the human oral cavity, and the upper and lower esophagus. Dis Esophagus 26(1):84–90CrossRefPubMed Norder Grusell E, Dahlén G, Ruth M, Ny L, Quiding-Järbrink M, Bergquist H et al (2013) Bacterial flora of the human oral cavity, and the upper and lower esophagus. Dis Esophagus 26(1):84–90CrossRefPubMed
82.
Zurück zum Zitat Dellon ES (2016) The esophageal microbiome in eosinophilic esophagitis. Gastroenterology. 151(2):364–365CrossRefPubMed Dellon ES (2016) The esophageal microbiome in eosinophilic esophagitis. Gastroenterology. 151(2):364–365CrossRefPubMed
83.
Zurück zum Zitat Benitez AJ, Hoffmann C, Muir AB, Dods KK, Spergel JM, Bushman FD et al (2015) Inflammation-associated microbiota in pediatric eosinophilic esophagitis. Microbiome. 3(1):23CrossRefPubMedPubMedCentral Benitez AJ, Hoffmann C, Muir AB, Dods KK, Spergel JM, Bushman FD et al (2015) Inflammation-associated microbiota in pediatric eosinophilic esophagitis. Microbiome. 3(1):23CrossRefPubMedPubMedCentral
84.
Zurück zum Zitat Hill DA, Siracusa MC, Abt MC, Kim BS, Kobuley D, Kubo M et al (2012) Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med 18(4):538–546CrossRefPubMedPubMedCentral Hill DA, Siracusa MC, Abt MC, Kim BS, Kobuley D, Kubo M et al (2012) Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation. Nat Med 18(4):538–546CrossRefPubMedPubMedCentral
85.
Zurück zum Zitat Stefka AT, Feehley T, Tripathi P, Qiu J, McCoy K, Mazmanian SK et al (2014) Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci 111(36):13145–13150CrossRefPubMed Stefka AT, Feehley T, Tripathi P, Qiu J, McCoy K, Mazmanian SK et al (2014) Commensal bacteria protect against food allergen sensitization. Proc Natl Acad Sci 111(36):13145–13150CrossRefPubMed
86.
Zurück zum Zitat Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ et al (2010) Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 3(2):148–158CrossRefPubMed Hill DA, Hoffmann C, Abt MC, Du Y, Kobuley D, Kirn TJ et al (2010) Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis. Mucosal Immunol 3(2):148–158CrossRefPubMed
87.
Zurück zum Zitat Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H et al (2016) Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med 8(343):343ra82CrossRefPubMedPubMedCentral Bokulich NA, Chung J, Battaglia T, Henderson N, Jay M, Li H et al (2016) Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med 8(343):343ra82CrossRefPubMedPubMedCentral
88.
Zurück zum Zitat Kummeling I, Stelma FF, Dagnelie PC, Snijders BEP, Penders J, Huber M et al (2007) Early life exposure to antibiotics and the subsequent development of eczema, wheeze, and allergic sensitization in the first 2 years of life: the KOALA birth cohort study. Pediatrics. 119(1):e225–e231CrossRefPubMed Kummeling I, Stelma FF, Dagnelie PC, Snijders BEP, Penders J, Huber M et al (2007) Early life exposure to antibiotics and the subsequent development of eczema, wheeze, and allergic sensitization in the first 2 years of life: the KOALA birth cohort study. Pediatrics. 119(1):e225–e231CrossRefPubMed
89.
Zurück zum Zitat Ahmadizar F, Vijverberg SJH, Arets HGM, de Boer A, Lang JE, Garssen J et al (2018) Early-life antibiotic exposure increases the risk of developing allergic symptoms later in life: a meta-analysis. Allergy 73(5):971–986CrossRefPubMed Ahmadizar F, Vijverberg SJH, Arets HGM, de Boer A, Lang JE, Garssen J et al (2018) Early-life antibiotic exposure increases the risk of developing allergic symptoms later in life: a meta-analysis. Allergy 73(5):971–986CrossRefPubMed
90.
Zurück zum Zitat Keag OE, Norman JE, Stock SJ (2018) Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: systematic review and meta-analysis. PLoS Med 15(1):e1002494CrossRefPubMedPubMedCentral Keag OE, Norman JE, Stock SJ (2018) Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: systematic review and meta-analysis. PLoS Med 15(1):e1002494CrossRefPubMedPubMedCentral
91.
Zurück zum Zitat Jensen ET, Kappelman MD, Kim HP, Ringel-Kulka T, Dellon ES (2013) Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 57(1):67–71CrossRefPubMed Jensen ET, Kappelman MD, Kim HP, Ringel-Kulka T, Dellon ES (2013) Early life exposures as risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 57(1):67–71CrossRefPubMed
92.
Zurück zum Zitat Radano MC, Yuan Q, Katz A, Fleming JT, Kubala S, Shreffler W et al (2014) Cesarean section and antibiotic use found to be associated with eosinophilic esophagitis. J Allergy Clin Immunol Pract 2(4):475–477.e1CrossRefPubMed Radano MC, Yuan Q, Katz A, Fleming JT, Kubala S, Shreffler W et al (2014) Cesarean section and antibiotic use found to be associated with eosinophilic esophagitis. J Allergy Clin Immunol Pract 2(4):475–477.e1CrossRefPubMed
93.
Zurück zum Zitat Jensen ET, Kuhl JT, Martin LJ, Rothenberg ME, Dellon ES (2018) Prenatal, intrapartum, and postnatal factors are associated with pediatric eosinophilic esophagitis. J Allergy Clin Immunol 141(1):214–222CrossRefPubMed Jensen ET, Kuhl JT, Martin LJ, Rothenberg ME, Dellon ES (2018) Prenatal, intrapartum, and postnatal factors are associated with pediatric eosinophilic esophagitis. J Allergy Clin Immunol 141(1):214–222CrossRefPubMed
94.
Zurück zum Zitat Jenson E, Shaheen O, Koutlas N, Chang AO, Martin L, Rothenberg M et al (2017) Early life factors are associated with risk for eosinophilic esophagitis diagnosed in adulthood. Gastroenterology 152(5):S861 Jenson E, Shaheen O, Koutlas N, Chang AO, Martin L, Rothenberg M et al (2017) Early life factors are associated with risk for eosinophilic esophagitis diagnosed in adulthood. Gastroenterology 152(5):S861
95.
Zurück zum Zitat Witmer CP, Susi A, Min SB, Nylund CM (2018) Early infant risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 67(5):610–615CrossRefPubMed Witmer CP, Susi A, Min SB, Nylund CM (2018) Early infant risk factors for pediatric eosinophilic esophagitis. J Pediatr Gastroenterol Nutr 67(5):610–615CrossRefPubMed
96.
Zurück zum Zitat Munblit D, Peroni DG, Boix-Amorós A, Hsu PS, Van’t Land B, Gay MCL et al (2017) Human milk and allergic diseases: an unsolved puzzle. Nutrients 9(8) Munblit D, Peroni DG, Boix-Amorós A, Hsu PS, Van’t Land B, Gay MCL et al (2017) Human milk and allergic diseases: an unsolved puzzle. Nutrients 9(8)
97.
Zurück zum Zitat Fogg MI, Ruchelli E, Spergel JM (2003) Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 112(4):796–797CrossRefPubMed Fogg MI, Ruchelli E, Spergel JM (2003) Pollen and eosinophilic esophagitis. J Allergy Clin Immunol 112(4):796–797CrossRefPubMed
98.
Zurück zum Zitat Onbasi K, Sin AZ, Doganavsargil B, Onder GF, Bor S, Sebik F (2005) Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy 35(11):1423–1431CrossRefPubMed Onbasi K, Sin AZ, Doganavsargil B, Onder GF, Bor S, Sebik F (2005) Eosinophil infiltration of the oesophageal mucosa in patients with pollen allergy during the season. Clin Exp Allergy 35(11):1423–1431CrossRefPubMed
99.
Zurück zum Zitat Wang FY, Gupta SK, Fitzgerald JF (2007) Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol 41(5):451–453CrossRefPubMed Wang FY, Gupta SK, Fitzgerald JF (2007) Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol 41(5):451–453CrossRefPubMed
100.
Zurück zum Zitat Moawad FJ, Veerappan GR, Lake JM, Maydonovitch CL, Haymore BR, Kosisky SE et al (2010) Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther 31(4):509–515CrossRefPubMed Moawad FJ, Veerappan GR, Lake JM, Maydonovitch CL, Haymore BR, Kosisky SE et al (2010) Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther 31(4):509–515CrossRefPubMed
101.
Zurück zum Zitat Prasad GA, Alexander JA, Schleck CD, Zinsmeister AR, Smyrk TC, Elias RM et al (2009) Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 7(10):1055–1061CrossRefPubMedPubMedCentral Prasad GA, Alexander JA, Schleck CD, Zinsmeister AR, Smyrk TC, Elias RM et al (2009) Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 7(10):1055–1061CrossRefPubMedPubMedCentral
102.
Zurück zum Zitat Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR et al (2009) Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol 104(4):828–833CrossRefPubMed Almansa C, Krishna M, Buchner AM, Ghabril MS, Talley N, DeVault KR et al (2009) Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol 104(4):828–833CrossRefPubMed
103.
Zurück zum Zitat Iwanczak B, Janczyk W, Ryzko J, Banaszkiewicz A, Radzikowski A, Jarocka-Cyrta E et al (2011) Eosinophilic esophagitis in children: frequency, clinical manifestations, endoscopic findings, and seasonal distribution. Adv Med Sci 56(2):151–157CrossRefPubMed Iwanczak B, Janczyk W, Ryzko J, Banaszkiewicz A, Radzikowski A, Jarocka-Cyrta E et al (2011) Eosinophilic esophagitis in children: frequency, clinical manifestations, endoscopic findings, and seasonal distribution. Adv Med Sci 56(2):151–157CrossRefPubMed
104.
Zurück zum Zitat Fahey L, Robinson G, Weinberger K, Giambrone AE, Solomon AB (2017) Correlation between aeroallergen levels and new diagnosis of eosinophilic esophagitis in New York City. J Pediatr Gastroenterol Nutr 64(1):22–25CrossRefPubMedPubMedCentral Fahey L, Robinson G, Weinberger K, Giambrone AE, Solomon AB (2017) Correlation between aeroallergen levels and new diagnosis of eosinophilic esophagitis in New York City. J Pediatr Gastroenterol Nutr 64(1):22–25CrossRefPubMedPubMedCentral
105.
Zurück zum Zitat Larsson H, Bergquist H, Bove M (2011) The incidence of esophageal bolus impaction: is there a seasonal variation? Otolaryngol Head Neck Surg 144(2):186–190CrossRefPubMed Larsson H, Bergquist H, Bove M (2011) The incidence of esophageal bolus impaction: is there a seasonal variation? Otolaryngol Head Neck Surg 144(2):186–190CrossRefPubMed
106.
Zurück zum Zitat Mishra A, Hogan SP, Brandt EB, Rothenberg ME (2001) An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 107(1):83–90CrossRefPubMedPubMedCentral Mishra A, Hogan SP, Brandt EB, Rothenberg ME (2001) An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 107(1):83–90CrossRefPubMedPubMedCentral
107.
Zurück zum Zitat Rayapudi M, Mavi P, Zhu X, Pandey AK, Abonia JP, Rothenberg ME et al (2010) Indoor insect allergens are potent inducers of experimental eosinophilic esophagitis in mice. J Leukoc Biol 88(2):337–346CrossRefPubMedPubMedCentral Rayapudi M, Mavi P, Zhu X, Pandey AK, Abonia JP, Rothenberg ME et al (2010) Indoor insect allergens are potent inducers of experimental eosinophilic esophagitis in mice. J Leukoc Biol 88(2):337–346CrossRefPubMedPubMedCentral
108.
Zurück zum Zitat Wolf WA, Jerath MR, Dellon ES (2013) De-novo onset of eosinophilic esophagitis after large volume allergen exposures. J Gastrointest Liver Dis 22(2):205–208 Wolf WA, Jerath MR, Dellon ES (2013) De-novo onset of eosinophilic esophagitis after large volume allergen exposures. J Gastrointest Liver Dis 22(2):205–208
109.
Zurück zum Zitat Miehlke S, Alpan O, Schröder S, Straumann A (2013) Induction of eosinophilic esophagitis by sublingual pollen immunotherapy. Case Rep Gastroenterol 7(3):363–368CrossRefPubMedPubMedCentral Miehlke S, Alpan O, Schröder S, Straumann A (2013) Induction of eosinophilic esophagitis by sublingual pollen immunotherapy. Case Rep Gastroenterol 7(3):363–368CrossRefPubMedPubMedCentral
110.
Zurück zum Zitat Antico A, Fante R (2014) Esophageal hypereosinophilia induced by grass sublingual immunotherapy. J Allergy Clin Immunol 133(5):1482–1484CrossRefPubMed Antico A, Fante R (2014) Esophageal hypereosinophilia induced by grass sublingual immunotherapy. J Allergy Clin Immunol 133(5):1482–1484CrossRefPubMed
111.
Zurück zum Zitat Jensen ET, Kuhl JT, Martin LJ, Langefeld CD, Dellon ES, Rothenberg ME (2018) Early-life environmental exposures interact with genetic susceptibility variants in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol 141(2):632–637.e5CrossRefPubMed Jensen ET, Kuhl JT, Martin LJ, Langefeld CD, Dellon ES, Rothenberg ME (2018) Early-life environmental exposures interact with genetic susceptibility variants in pediatric patients with eosinophilic esophagitis. J Allergy Clin Immunol 141(2):632–637.e5CrossRefPubMed
112.
Zurück zum Zitat Van Rhijn BD, Van Ree R, Versteeg SA, Vlieg-Boerstra BJ, Sprikkelman AB, Terreehorst I et al (2013) Birch pollen sensitization with cross-reactivity to food allergens predominates in adults with eosinophilic esophagitis. Allergy 68(11):1475–1481CrossRefPubMed Van Rhijn BD, Van Ree R, Versteeg SA, Vlieg-Boerstra BJ, Sprikkelman AB, Terreehorst I et al (2013) Birch pollen sensitization with cross-reactivity to food allergens predominates in adults with eosinophilic esophagitis. Allergy 68(11):1475–1481CrossRefPubMed
113.
Zurück zum Zitat Frederickson NW, Bayman L, Valestin J, Redd M, Lee YJ, Soubra M et al (2014) Lack of seasonal variation in the incidence of eosinophilic oesophagitis in adolescent and adult non-PPI-responsive oesophageal eosinophilia midwestern US populations. United European Gastroenterol J 2(2):69–76CrossRefPubMedPubMedCentral Frederickson NW, Bayman L, Valestin J, Redd M, Lee YJ, Soubra M et al (2014) Lack of seasonal variation in the incidence of eosinophilic oesophagitis in adolescent and adult non-PPI-responsive oesophageal eosinophilia midwestern US populations. United European Gastroenterol J 2(2):69–76CrossRefPubMedPubMedCentral
114.
Zurück zum Zitat Elitsur Y, Aswani R, Lund V, Dementieva Y (2013) Seasonal distribution and eosinophilic esophagitis: the experience in children living in rural communities. J Clin Gastroenterol 47(3):287–288CrossRefPubMed Elitsur Y, Aswani R, Lund V, Dementieva Y (2013) Seasonal distribution and eosinophilic esophagitis: the experience in children living in rural communities. J Clin Gastroenterol 47(3):287–288CrossRefPubMed
115.
Zurück zum Zitat Sorser SA, Barawi M, Hagglund K, Almojaned M, Lyons H (2013) Eosinophilic esophagitis in children and adolescents: epidemiology, clinical presentation and seasonal variation. J Gastroenterol 48(1):81–85CrossRefPubMed Sorser SA, Barawi M, Hagglund K, Almojaned M, Lyons H (2013) Eosinophilic esophagitis in children and adolescents: epidemiology, clinical presentation and seasonal variation. J Gastroenterol 48(1):81–85CrossRefPubMed
116.
Zurück zum Zitat Lucendo AJ, Arias A, Redondo-González O, González-Cervera J (2015) Seasonal distribution of initial diagnosis and clinical recrudescence of eosinophilic esophagitis: a systematic review and meta-analysis. Allergy Eur J Allergy Clin Immunol. 70(12):1640–1650CrossRef Lucendo AJ, Arias A, Redondo-González O, González-Cervera J (2015) Seasonal distribution of initial diagnosis and clinical recrudescence of eosinophilic esophagitis: a systematic review and meta-analysis. Allergy Eur J Allergy Clin Immunol. 70(12):1640–1650CrossRef
117.
Zurück zum Zitat Fuentes-Aparicio V, Alvarez-Perea A, Infante S, Zapatero L, D’Oleo A, Alonso-Lebrero E (2013) Specific oral tolerance induction in paediatric patients with persistent egg allergy. Allergol Immunopathol (Madr) 41(3):143–150CrossRef Fuentes-Aparicio V, Alvarez-Perea A, Infante S, Zapatero L, D’Oleo A, Alonso-Lebrero E (2013) Specific oral tolerance induction in paediatric patients with persistent egg allergy. Allergol Immunopathol (Madr) 41(3):143–150CrossRef
118.
Zurück zum Zitat Hofmann AM, Scurlock AM, Jones SM, Palmer KP, Lokhnygina Y, Steele PH et al (2009) Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 124(2):286–291CrossRefPubMedPubMedCentral Hofmann AM, Scurlock AM, Jones SM, Palmer KP, Lokhnygina Y, Steele PH et al (2009) Safety of a peanut oral immunotherapy protocol in children with peanut allergy. J Allergy Clin Immunol 124(2):286–291CrossRefPubMedPubMedCentral
119.
Zurück zum Zitat Lucendo AJ, Arias Á, Tenias JM (2014) Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 113(6):624–629CrossRefPubMed Lucendo AJ, Arias Á, Tenias JM (2014) Relation between eosinophilic esophagitis and oral immunotherapy for food allergy: a systematic review with meta-analysis. Ann Allergy Asthma Immunol 113(6):624–629CrossRefPubMed
120.
Zurück zum Zitat Hsieh FH (2014) Oral food immunotherapy and iatrogenic eosinophilic esophagitis: an acceptable level of risk? Ann allergy. Asthma Immunol. 113(6):581–582CrossRef Hsieh FH (2014) Oral food immunotherapy and iatrogenic eosinophilic esophagitis: an acceptable level of risk? Ann allergy. Asthma Immunol. 113(6):581–582CrossRef
121.
Zurück zum Zitat Hill DA, Shuker M, Cianferoni A, Wong T, Ruchelli E, Spergel JM et al The development of IgE-mediated immediate hypersensitivity after the diagnosis of eosinophilic esophagitis to the same food. J Allergy Clin Immunol Pract 3(1):123–124 Hill DA, Shuker M, Cianferoni A, Wong T, Ruchelli E, Spergel JM et al The development of IgE-mediated immediate hypersensitivity after the diagnosis of eosinophilic esophagitis to the same food. J Allergy Clin Immunol Pract 3(1):123–124
122.
Zurück zum Zitat Soller L, Mill C, Avinashi V, Teoh T, Chan ES Development of anaphylactic cow’s milk allergy following cow’s milk elimination for eosinophilic esophagitis in a teenager. J Allergy Clin Immunol Pract 5(5):1413–1414 Soller L, Mill C, Avinashi V, Teoh T, Chan ES Development of anaphylactic cow’s milk allergy following cow’s milk elimination for eosinophilic esophagitis in a teenager. J Allergy Clin Immunol Pract 5(5):1413–1414
123.
Zurück zum Zitat Ho H-E, Chehade M Development of IgE-mediated immediate hypersensitivity to a previously tolerated food following its avoidance for eosinophilic gastrointestinal diseases. J allergy Clin Immunol Pract 6(2):649–650 Ho H-E, Chehade M Development of IgE-mediated immediate hypersensitivity to a previously tolerated food following its avoidance for eosinophilic gastrointestinal diseases. J allergy Clin Immunol Pract 6(2):649–650
124.
Zurück zum Zitat Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D et al (2017) Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 153(2):420–429CrossRefPubMed Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D et al (2017) Global prevalence of helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology. 153(2):420–429CrossRefPubMed
125.
Zurück zum Zitat Nguyen T, Ramsey D, Graham D, Shaib Y, Shiota S, Velez M et al (2015) The prevalence of helicobacter pylori remains high in African American and Hispanic veterans. Helicobacter. 20(4):305–315CrossRefPubMed Nguyen T, Ramsey D, Graham D, Shaib Y, Shiota S, Velez M et al (2015) The prevalence of helicobacter pylori remains high in African American and Hispanic veterans. Helicobacter. 20(4):305–315CrossRefPubMed
126.
Zurück zum Zitat Roberts SE, Morrison-Rees S, Samuel DG, Thorne K, Akbari A, Williams JG (2016) Review article: the prevalence of helicobacter pylori and the incidence of gastric cancer across Europe. Aliment Pharmacol Ther 43(3):334–345CrossRefPubMed Roberts SE, Morrison-Rees S, Samuel DG, Thorne K, Akbari A, Williams JG (2016) Review article: the prevalence of helicobacter pylori and the incidence of gastric cancer across Europe. Aliment Pharmacol Ther 43(3):334–345CrossRefPubMed
127.
Zurück zum Zitat Ronkainen J, Talley NJ, Aro P, Storskrubb T, Johansson SE, Lind T et al (2007) Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 56(5):615–620CrossRefPubMed Ronkainen J, Talley NJ, Aro P, Storskrubb T, Johansson SE, Lind T et al (2007) Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut. 56(5):615–620CrossRefPubMed
128.
Zurück zum Zitat Elitsur Y, Alrazzak BA, Preston D, Demetieva Y (2014) Does helicobacter pylori protect against eosinophilic esophagitis in children? Helicobacter. 19(5):367–371CrossRefPubMed Elitsur Y, Alrazzak BA, Preston D, Demetieva Y (2014) Does helicobacter pylori protect against eosinophilic esophagitis in children? Helicobacter. 19(5):367–371CrossRefPubMed
129.
Zurück zum Zitat Von Arnim U, Wex T, Link A, Messerschmidt M, Venerito M, Miehlke S et al (2016) Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis. Aliment Pharmacol Ther 43(7):825–830CrossRef Von Arnim U, Wex T, Link A, Messerschmidt M, Venerito M, Miehlke S et al (2016) Helicobacter pylori infection is associated with a reduced risk of developing eosinophilic oesophagitis. Aliment Pharmacol Ther 43(7):825–830CrossRef
130.
Zurück zum Zitat Sonnenberg A, Dellon ES, Turner KO, Genta RM (2017) The influence of Helicobacter pylori on the ethnic distribution of esophageal eosinophilia. Helicobacter 22(3) Sonnenberg A, Dellon ES, Turner KO, Genta RM (2017) The influence of Helicobacter pylori on the ethnic distribution of esophageal eosinophilia. Helicobacter 22(3)
131.
Zurück zum Zitat Dellon ES, Peery AF, Shaheen NJ, Morgan DR, Hurrell JM, Lash RHGR (2011) Inverse association of esophageal eosinophilia with helicobacter pylori based on analysis of a US pathology database. Gastroenterology. 141(5):1586–1592CrossRefPubMedPubMedCentral Dellon ES, Peery AF, Shaheen NJ, Morgan DR, Hurrell JM, Lash RHGR (2011) Inverse association of esophageal eosinophilia with helicobacter pylori based on analysis of a US pathology database. Gastroenterology. 141(5):1586–1592CrossRefPubMedPubMedCentral
132.
Zurück zum Zitat Furuta K, Adachi K, Aimi M, Ishimura N, Sato S, Ishihara S et al (2013) Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J Clin Biochem Nutr 53(1):60–62CrossRefPubMedPubMedCentral Furuta K, Adachi K, Aimi M, Ishimura N, Sato S, Ishihara S et al (2013) Case-control study of association of eosinophilic gastrointestinal disorders with Helicobacter pylori infection in Japan. J Clin Biochem Nutr 53(1):60–62CrossRefPubMedPubMedCentral
134.
Zurück zum Zitat Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C et al (2011) Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 121(8):3088–3093CrossRefPubMedPubMedCentral Arnold IC, Dehzad N, Reuter S, Martin H, Becher B, Taube C et al (2011) Helicobacter pylori infection prevents allergic asthma in mouse models through the induction of regulatory T cells. J Clin Invest 121(8):3088–3093CrossRefPubMedPubMedCentral
135.
Zurück zum Zitat Molina-Infante J, Gutierrez-Junquera C, Savarino E, Penagini R, Modolell I, Bartolo O et al (2018) Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study. Am J Gastroenterol 113(7):972–979CrossRefPubMed Molina-Infante J, Gutierrez-Junquera C, Savarino E, Penagini R, Modolell I, Bartolo O et al (2018) Helicobacter pylori infection does not protect against eosinophilic esophagitis: results from a large multicenter case-control study. Am J Gastroenterol 113(7):972–979CrossRefPubMed
136.
Zurück zum Zitat Blanchard C, Stucke EM, Rodriguez-Jimenez B, Burwinkel K, Collins MH, Ahrens A et al (2011) A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol. 127(1):208–217CrossRefPubMedPubMedCentral Blanchard C, Stucke EM, Rodriguez-Jimenez B, Burwinkel K, Collins MH, Ahrens A et al (2011) A striking local esophageal cytokine expression profile in eosinophilic esophagitis. J Allergy Clin Immunol. 127(1):208–217CrossRefPubMedPubMedCentral
137.
Zurück zum Zitat Sherrill JD, Kiran KC, Blanchard C, Stucke EM, Kemme KA, Collins MH, Abonia JP, Putnam PE, Mukkada VA, Kaul A, Kocoshis SA, Kushner JP, Plassard AJ, Karns RA, Dexheimer PJ, Aronow BJRM (2014) Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing. Genes Immun 15(6):361–369CrossRefPubMedPubMedCentral Sherrill JD, Kiran KC, Blanchard C, Stucke EM, Kemme KA, Collins MH, Abonia JP, Putnam PE, Mukkada VA, Kaul A, Kocoshis SA, Kushner JP, Plassard AJ, Karns RA, Dexheimer PJ, Aronow BJRM (2014) Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing. Genes Immun 15(6):361–369CrossRefPubMedPubMedCentral
138.
Zurück zum Zitat Henderson CJ, Abonia JP, King EC, Putnam PE, Collins MH, Franciosi JP et al (2012) Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol 129(6):1570–1578CrossRefPubMedPubMedCentral Henderson CJ, Abonia JP, King EC, Putnam PE, Collins MH, Franciosi JP et al (2012) Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitis. J Allergy Clin Immunol 129(6):1570–1578CrossRefPubMedPubMedCentral
139.
Zurück zum Zitat Lucendo AJ (2015) Meta-analysis-based guidance for dietary management in eosinophilic esophagitis. Curr Gastroenterol Rep 17(10):464CrossRefPubMed Lucendo AJ (2015) Meta-analysis-based guidance for dietary management in eosinophilic esophagitis. Curr Gastroenterol Rep 17(10):464CrossRefPubMed
140.
Zurück zum Zitat Markowitz JE, Spergel JM, Ruchelli ELC (2003) Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 98(4):777–782CrossRefPubMed Markowitz JE, Spergel JM, Ruchelli ELC (2003) Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am J Gastroenterol 98(4):777–782CrossRefPubMed
141.
Zurück zum Zitat Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H et al (2010) Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 65(1):109–116CrossRefPubMed Aceves SS, Newbury RO, Chen D, Mueller J, Dohil R, Hoffman H et al (2010) Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 65(1):109–116CrossRefPubMed
142.
Zurück zum Zitat Rajan J, Newbury RO, Anilkumar A, Dohil R, Broide DH, Aceves SS (2016) Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol 137(1):147–156.e8CrossRefPubMed Rajan J, Newbury RO, Anilkumar A, Dohil R, Broide DH, Aceves SS (2016) Long-term assessment of esophageal remodeling in patients with pediatric eosinophilic esophagitis treated with topical corticosteroids. J Allergy Clin Immunol 137(1):147–156.e8CrossRefPubMed
143.
Zurück zum Zitat Konikoff MR, Noel RJ, Blanchard C, Kirby C, Jameson SC, Buckmeier BK et al (2006) A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 131(5):1381–1391CrossRefPubMed Konikoff MR, Noel RJ, Blanchard C, Kirby C, Jameson SC, Buckmeier BK et al (2006) A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology. 131(5):1381–1391CrossRefPubMed
144.
Zurück zum Zitat Noel RJ, Putnam PE, Collins MH, Assa’ad AH, Guajardo JR, Jameson SC et al (2004) Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2(7):568–575CrossRefPubMed Noel RJ, Putnam PE, Collins MH, Assa’ad AH, Guajardo JR, Jameson SC et al (2004) Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin Gastroenterol Hepatol 2(7):568–575CrossRefPubMed
145.
Zurück zum Zitat Butz BK, Wen T, Gleich GJ, Furuta GT, Spergel J, King E et al (2014) Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. Gastroenterology 147(2):324–33.e5CrossRefPubMedPubMedCentral Butz BK, Wen T, Gleich GJ, Furuta GT, Spergel J, King E et al (2014) Efficacy, dose reduction, and resistance to high-dose fluticasone in patients with eosinophilic esophagitis. Gastroenterology 147(2):324–33.e5CrossRefPubMedPubMedCentral
146.
Zurück zum Zitat Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, Schoepfer ASH (2011) Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 9(5):400–9.e1CrossRefPubMed Straumann A, Conus S, Degen L, Frei C, Bussmann C, Beglinger C, Schoepfer ASH (2011) Long-term budesonide maintenance treatment is partially effective for patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol 9(5):400–9.e1CrossRefPubMed
147.
Zurück zum Zitat Aceves SS, Bastian JF, Newbury RO, Dohil R (2007) Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 102(10):2271–2279CrossRefPubMed Aceves SS, Bastian JF, Newbury RO, Dohil R (2007) Oral viscous budesonide: a potential new therapy for eosinophilic esophagitis in children. Am J Gastroenterol 102(10):2271–2279CrossRefPubMed
148.
149.
Zurück zum Zitat Zarowiecki M, Berriman M (2015) What helminth genomes have taught us about parasite evolution. Parasitology. 142:S85–S97CrossRefPubMed Zarowiecki M, Berriman M (2015) What helminth genomes have taught us about parasite evolution. Parasitology. 142:S85–S97CrossRefPubMed
150.
Zurück zum Zitat Scott IC, Rees DG, Cohen ES (2018) New perspectives on IL-33 and IL-1 family cytokines as innate environmental sensors. Biochem Soc Trans 46(5):1345–1353CrossRefPubMed Scott IC, Rees DG, Cohen ES (2018) New perspectives on IL-33 and IL-1 family cytokines as innate environmental sensors. Biochem Soc Trans 46(5):1345–1353CrossRefPubMed
151.
Zurück zum Zitat Cayrol C, Duval A, Schmitt P, Roga S, Camus M, Stella A et al (2018) Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33. Nat Immunol 19(4):375–385CrossRefPubMed Cayrol C, Duval A, Schmitt P, Roga S, Camus M, Stella A et al (2018) Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33. Nat Immunol 19(4):375–385CrossRefPubMed
152.
Zurück zum Zitat Sokol CL, Barton GM, Farr AG, Medzhitov R (2008) A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 9(3):310–318CrossRefPubMedPubMedCentral Sokol CL, Barton GM, Farr AG, Medzhitov R (2008) A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol 9(3):310–318CrossRefPubMedPubMedCentral
153.
Zurück zum Zitat Farhan RK, Vickers MA, Ghaemmaghami AM, Hall AM, Barker RN, Walsh GM (2016) Effective antigen presentation to helper T cells by human eosinophils. Immunology. 149(4):413–422CrossRefPubMedPubMedCentral Farhan RK, Vickers MA, Ghaemmaghami AM, Hall AM, Barker RN, Walsh GM (2016) Effective antigen presentation to helper T cells by human eosinophils. Immunology. 149(4):413–422CrossRefPubMedPubMedCentral
154.
Zurück zum Zitat Svensson L, Rudin A, Wennerås C (2004) Allergen extracts directly mobilize and activate human eosinophils. Eur J Immunol 34(6):1744–1751CrossRefPubMed Svensson L, Rudin A, Wennerås C (2004) Allergen extracts directly mobilize and activate human eosinophils. Eur J Immunol 34(6):1744–1751CrossRefPubMed
155.
Zurück zum Zitat Machado DC, Horton D, Harrop R, Peachell PT, Helm BA (1996) Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE. Eur J Immunol 26(12):2972–2980CrossRefPubMed Machado DC, Horton D, Harrop R, Peachell PT, Helm BA (1996) Potential allergens stimulate the release of mediators of the allergic response from cells of mast cell lineage in the absence of sensitization with antigen-specific IgE. Eur J Immunol 26(12):2972–2980CrossRefPubMed
156.
Zurück zum Zitat Liang G, Barker T, Xie Z, Charles N, Rivera J, Druey KM (2012) Naive T cells sense the cysteine protease allergen papain through protease-activated receptor 2 and propel T H2 immunity. J Allergy Clin Immunol 129(5):1377–1386.e13CrossRefPubMedPubMedCentral Liang G, Barker T, Xie Z, Charles N, Rivera J, Druey KM (2012) Naive T cells sense the cysteine protease allergen papain through protease-activated receptor 2 and propel T H2 immunity. J Allergy Clin Immunol 129(5):1377–1386.e13CrossRefPubMedPubMedCentral
157.
Zurück zum Zitat Palm NW, Rosenstein RK, Yu S, Schenten DD, Florsheim E, Medzhitov R (2013) Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity. 39(5):976–985CrossRefPubMed Palm NW, Rosenstein RK, Yu S, Schenten DD, Florsheim E, Medzhitov R (2013) Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity. Immunity. 39(5):976–985CrossRefPubMed
158.
Zurück zum Zitat Masilamani M, Commins S, Shreffler W (2012) Determinants of food allergy. Immunol Allergy Clin N Am 32(1):11–33CrossRef Masilamani M, Commins S, Shreffler W (2012) Determinants of food allergy. Immunol Allergy Clin N Am 32(1):11–33CrossRef
159.
Zurück zum Zitat Chapman MD, Wünschmann S, Pomés A (2007) Proteases as Th2 adjuvants. Curr Allergy Asthma Rep 7(5):363–367CrossRefPubMed Chapman MD, Wünschmann S, Pomés A (2007) Proteases as Th2 adjuvants. Curr Allergy Asthma Rep 7(5):363–367CrossRefPubMed
160.
Zurück zum Zitat Reed CE, Kita H (2004) The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 114(5):997–1008CrossRefPubMed Reed CE, Kita H (2004) The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol 114(5):997–1008CrossRefPubMed
161.
Zurück zum Zitat Borisov IN, Zashikhin AL (1978) Specific secretory inclusions in the pyloric part of the mouse stomach. Bull Exp Biol Med 86(6):1672–1674 Borisov IN, Zashikhin AL (1978) Specific secretory inclusions in the pyloric part of the mouse stomach. Bull Exp Biol Med 86(6):1672–1674
162.
Zurück zum Zitat Pesek RD, Rettiganti M, O’Brien E, Beckwith S, Daniel C, Luo C et al (2017) Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitis. Ann Allergy Asthma Immunol 119(2):177–183CrossRefPubMedPubMedCentral Pesek RD, Rettiganti M, O’Brien E, Beckwith S, Daniel C, Luo C et al (2017) Effects of allergen sensitization on response to therapy in children with eosinophilic esophagitis. Ann Allergy Asthma Immunol 119(2):177–183CrossRefPubMedPubMedCentral
163.
Zurück zum Zitat Akei HS, Mishra A, Blanchard C, Rothenberg ME (2005) Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology. 129(3):985–994CrossRefPubMed Akei HS, Mishra A, Blanchard C, Rothenberg ME (2005) Epicutaneous antigen exposure primes for experimental eosinophilic esophagitis in mice. Gastroenterology. 129(3):985–994CrossRefPubMed
164.
Zurück zum Zitat John RJ, Rusznak C, Ramjee M, Lamont AG, Abrahamson M, Hewitt EL (2000) Functional effects of the inhibition of the cysteine protease activity of the major house dust mite allergen Der p 1 by a novel peptide-based inhibitor. Clin Exp Allergy 30(6):784–793CrossRefPubMed John RJ, Rusznak C, Ramjee M, Lamont AG, Abrahamson M, Hewitt EL (2000) Functional effects of the inhibition of the cysteine protease activity of the major house dust mite allergen Der p 1 by a novel peptide-based inhibitor. Clin Exp Allergy 30(6):784–793CrossRefPubMed
165.
Zurück zum Zitat Schulz O, Sewell HF, Shakib F (1998) Proteolytic cleavage of CD25, the α subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J Exp Med 187(2):271–275CrossRefPubMedPubMedCentral Schulz O, Sewell HF, Shakib F (1998) Proteolytic cleavage of CD25, the α subunit of the human T cell interleukin 2 receptor, by Der p 1, a major mite allergen with cysteine protease activity. J Exp Med 187(2):271–275CrossRefPubMedPubMedCentral
166.
Zurück zum Zitat Rochman M, Travers J, Miracle CE, Bedard MC, Wen T, Azouz NP et al (2017) Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis. J Allergy Clin Immunol 140(3):738–749.e3CrossRefPubMedPubMedCentral Rochman M, Travers J, Miracle CE, Bedard MC, Wen T, Azouz NP et al (2017) Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis. J Allergy Clin Immunol 140(3):738–749.e3CrossRefPubMedPubMedCentral
167.
Zurück zum Zitat Azouz NP, Ynga-Durand MA, Caldwell JM, Jain A, Rochman M, Fischesser DM et al (2018) The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responses. Sci Transl Med 10(444) Azouz NP, Ynga-Durand MA, Caldwell JM, Jain A, Rochman M, Fischesser DM et al (2018) The antiprotease SPINK7 serves as an inhibitory checkpoint for esophageal epithelial inflammatory responses. Sci Transl Med 10(444)
168.
Zurück zum Zitat Rochman M, Azouz NP, Rothenberg ME (2018) Epithelial origin of eosinophilic esophagitis. J Allergy Clin Immunol 142(1):10–23CrossRefPubMed Rochman M, Azouz NP, Rothenberg ME (2018) Epithelial origin of eosinophilic esophagitis. J Allergy Clin Immunol 142(1):10–23CrossRefPubMed
169.
Zurück zum Zitat Schleimer RP, Berdnikovs S (2017) Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases. J Allergy Clin Immunol 139(6):1752–1761CrossRefPubMedPubMedCentral Schleimer RP, Berdnikovs S (2017) Etiology of epithelial barrier dysfunction in patients with type 2 inflammatory diseases. J Allergy Clin Immunol 139(6):1752–1761CrossRefPubMedPubMedCentral
170.
Zurück zum Zitat Garcia-Hernandez V, Quiros M, Nusrat A (2017) Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation. Ann N Y Acad Sci 1397(1):66–79CrossRefPubMedPubMedCentral Garcia-Hernandez V, Quiros M, Nusrat A (2017) Intestinal epithelial claudins: expression and regulation in homeostasis and inflammation. Ann N Y Acad Sci 1397(1):66–79CrossRefPubMedPubMedCentral
171.
Zurück zum Zitat Mowat AM, Agace WW (2014) Regional specialization within the intestinal immune system. Nat Rev Immunol 14(10):667–685CrossRefPubMed Mowat AM, Agace WW (2014) Regional specialization within the intestinal immune system. Nat Rev Immunol 14(10):667–685CrossRefPubMed
172.
Zurück zum Zitat Hill DA, Faubion W (2017) The intestinal immune system during homeostasis and inflammatory bowel disease. Pediatric inflammatory bowel disease: Third Edition. In: Mamula P, Grossman A, Baldassano R, MJ KJ (eds) Pediatric Inflammatory Bowel Disease: Third Edition, 3rd edn. Springer International Publishing, New York Hill DA, Faubion W (2017) The intestinal immune system during homeostasis and inflammatory bowel disease. Pediatric inflammatory bowel disease: Third Edition. In: Mamula P, Grossman A, Baldassano R, MJ KJ (eds) Pediatric Inflammatory Bowel Disease: Third Edition, 3rd edn. Springer International Publishing, New York
173.
Zurück zum Zitat Palmer CNA, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38(4):441–446CrossRefPubMed Palmer CNA, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP et al (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38(4):441–446CrossRefPubMed
174.
Zurück zum Zitat Samuelov L, Sarig O, Harmon RM, Rapaport D, Ishida-Yamamoto A, Isakov O et al (2013) Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet 45(10):1244–1248CrossRefPubMedPubMedCentral Samuelov L, Sarig O, Harmon RM, Rapaport D, Ishida-Yamamoto A, Isakov O et al (2013) Desmoglein 1 deficiency results in severe dermatitis, multiple allergies and metabolic wasting. Nat Genet 45(10):1244–1248CrossRefPubMedPubMedCentral
175.
Zurück zum Zitat McAleer MA, Pohler E, Smith FJD, Wilson NJ, Cole C, Macgowan S et al (2015) Severe dermatitis, multiple allergies, and metabolic wasting syndrome caused by a novel mutation in the N-terminal plakin domain of desmoplakin. J Allergy Clin Immunol 136(5):1268–1276CrossRefPubMedPubMedCentral McAleer MA, Pohler E, Smith FJD, Wilson NJ, Cole C, Macgowan S et al (2015) Severe dermatitis, multiple allergies, and metabolic wasting syndrome caused by a novel mutation in the N-terminal plakin domain of desmoplakin. J Allergy Clin Immunol 136(5):1268–1276CrossRefPubMedPubMedCentral
176.
Zurück zum Zitat De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C et al (2011) Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 127(3):773–786CrossRef De Benedetto A, Rafaels NM, McGirt LY, Ivanov AI, Georas SN, Cheadle C et al (2011) Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 127(3):773–786CrossRef
177.
Zurück zum Zitat Sweerus K, Lachowicz-Scroggins M, Gordon E, LaFemina M, Huang X, Parikh M et al (2017) Claudin-18 deficiency is associated with airway epithelial barrier dysfunction and asthma. J Allergy Clin Immunol 139(1):72–81.e1CrossRefPubMed Sweerus K, Lachowicz-Scroggins M, Gordon E, LaFemina M, Huang X, Parikh M et al (2017) Claudin-18 deficiency is associated with airway epithelial barrier dysfunction and asthma. J Allergy Clin Immunol 139(1):72–81.e1CrossRefPubMed
178.
Zurück zum Zitat Simon D, Page B, Vogel M, Bussmann C, Blanchard C, Straumann A et al (2018) Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis. Allergy 73(1):239–247CrossRefPubMed Simon D, Page B, Vogel M, Bussmann C, Blanchard C, Straumann A et al (2018) Evidence of an abnormal epithelial barrier in active, untreated and corticosteroid-treated eosinophilic esophagitis. Allergy 73(1):239–247CrossRefPubMed
179.
Zurück zum Zitat Kc K, Rothenberg MESJ (2015) In vitro model for studying esophageal epithelial differentiation and allergic inflammatory responses identifies keratin involvement in eosinophilic esophagitis. PLoS One 10(6):e0127755CrossRefPubMedPubMedCentral Kc K, Rothenberg MESJ (2015) In vitro model for studying esophageal epithelial differentiation and allergic inflammatory responses identifies keratin involvement in eosinophilic esophagitis. PLoS One 10(6):e0127755CrossRefPubMedPubMedCentral
180.
Zurück zum Zitat Sherrill JD, Kc K, Wu D, Djukic Z, Caldwell JM, Stucke EM et al (2014) Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol 7(3):718–729CrossRefPubMed Sherrill JD, Kc K, Wu D, Djukic Z, Caldwell JM, Stucke EM et al (2014) Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunol 7(3):718–729CrossRefPubMed
181.
Zurück zum Zitat Van Rhijn BD, Verheij J, Van Den Bergh Weerman MA, Verseijden C, Van Den Wijngaard RMJGJ, De Jonge WJ et al (2015) Histological response to fluticasone propionate in patients with eosinophilic esophagitis is associated with improved functional esophageal mucosal integrity. Am J Gastroenterol 110(9):1289–1297CrossRefPubMed Van Rhijn BD, Verheij J, Van Den Bergh Weerman MA, Verseijden C, Van Den Wijngaard RMJGJ, De Jonge WJ et al (2015) Histological response to fluticasone propionate in patients with eosinophilic esophagitis is associated with improved functional esophageal mucosal integrity. Am J Gastroenterol 110(9):1289–1297CrossRefPubMed
182.
Zurück zum Zitat Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, Lu TX et al (2007) IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 120(6):1292–1300CrossRefPubMed Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, Lu TX et al (2007) IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 120(6):1292–1300CrossRefPubMed
183.
Zurück zum Zitat Tordesillas L, Goswami R, Benedé S, Grishina G, Dunkin D, Järvinen KM et al (2014) Skin exposure promotes a Th2-dependent sensitization to peanut allergens. Journal of Clinical Investigation 124(11):4965–4975 Tordesillas L, Goswami R, Benedé S, Grishina G, Dunkin D, Järvinen KM et al (2014) Skin exposure promotes a Th2-dependent sensitization to peanut allergens. Journal of Clinical Investigation 124(11):4965–4975
184.
Zurück zum Zitat Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS (1998) Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.. Journal of Clinical Investigation 101(8):1614–1622 Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS (1998) Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice.. Journal of Clinical Investigation 101(8):1614–1622
186.
Zurück zum Zitat Hill DA, Siracusa MC, Ruymann KR, Tait Wojno ED, Artis D, Spergel JM (2014) Omalizumab therapy is associated with reduced circulating basophil populations in asthmatic children. Allergy 69(5):674–677CrossRefPubMedPubMedCentral Hill DA, Siracusa MC, Ruymann KR, Tait Wojno ED, Artis D, Spergel JM (2014) Omalizumab therapy is associated with reduced circulating basophil populations in asthmatic children. Allergy 69(5):674–677CrossRefPubMedPubMedCentral
187.
Zurück zum Zitat Venturelli N, Lexmond WS, Ohsaki A, Nurko S, Karasuyama H, Fiebiger E et al (2016) Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33–basophil axis in mice. J Allergy Clin Immunol 138(5):1367–1380.e5CrossRefPubMed Venturelli N, Lexmond WS, Ohsaki A, Nurko S, Karasuyama H, Fiebiger E et al (2016) Allergic skin sensitization promotes eosinophilic esophagitis through the IL-33–basophil axis in mice. J Allergy Clin Immunol 138(5):1367–1380.e5CrossRefPubMed
188.
Zurück zum Zitat Rothenberg ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon H-U et al (2008) Treatment of patients with the Hypereosinophilic syndrome with mepolizumab. N Engl J Med 358(12):1215–1228CrossRefPubMed Rothenberg ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon H-U et al (2008) Treatment of patients with the Hypereosinophilic syndrome with mepolizumab. N Engl J Med 358(12):1215–1228CrossRefPubMed
189.
Zurück zum Zitat Kim S, Marigowda G, Oren E, Israel E, Wechsler ME (2010) Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. J Allergy Clin Immunol 125(6):1336–1343CrossRefPubMed Kim S, Marigowda G, Oren E, Israel E, Wechsler ME (2010) Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome. J Allergy Clin Immunol 125(6):1336–1343CrossRefPubMed
191.
Zurück zum Zitat Hamelmann E, Cieslewicz G, Schwarze J, Ishizuka T, Joetham A, Heusser C et al (1999) Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness. Am J Respir Crit Care Med 160(3):934–941CrossRefPubMed Hamelmann E, Cieslewicz G, Schwarze J, Ishizuka T, Joetham A, Heusser C et al (1999) Anti-interleukin 5 but not anti-IgE prevents airway inflammation and airway hyperresponsiveness. Am J Respir Crit Care Med 160(3):934–941CrossRefPubMed
192.
Zurück zum Zitat Lee JJ, Dimina D, Macias MMP, Ochkur SI, McGarry MP, O’Neill KR et al (2004) Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305(5691):1773–1776CrossRefPubMed Lee JJ, Dimina D, Macias MMP, Ochkur SI, McGarry MP, O’Neill KR et al (2004) Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305(5691):1773–1776CrossRefPubMed
193.
Zurück zum Zitat Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SHGC (2004) A critical role for eosinophils in allergic airways remodeling. Science 305(5691):1776–1779CrossRefPubMed Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE, Ghiran S, Gerard NP, Yu C, Orkin SHGC (2004) A critical role for eosinophils in allergic airways remodeling. Science 305(5691):1776–1779CrossRefPubMed
194.
Zurück zum Zitat Stein ML, Collins MH, Villanueva JM, Kushner JP, Putnam PE, Buckmeier BK et al (2006) Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 118(6):1312–1319CrossRefPubMed Stein ML, Collins MH, Villanueva JM, Kushner JP, Putnam PE, Buckmeier BK et al (2006) Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J Allergy Clin Immunol 118(6):1312–1319CrossRefPubMed
195.
Zurück zum Zitat Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C et al (2010) Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut. 59(1):21–30CrossRefPubMed Straumann A, Conus S, Grzonka P, Kita H, Kephart G, Bussmann C et al (2010) Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut. 59(1):21–30CrossRefPubMed
196.
Zurück zum Zitat Assa’ad AH, Gupta SK, Collins MH, Thomson M, Heath AT, Smith DA, Perschy TL, Jurgensen CH, Ortega HGAS (2011) An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 141(5):1593–1604CrossRefPubMed Assa’ad AH, Gupta SK, Collins MH, Thomson M, Heath AT, Smith DA, Perschy TL, Jurgensen CH, Ortega HGAS (2011) An antibody against IL-5 reduces numbers of esophageal intraepithelial eosinophils in children with eosinophilic esophagitis. Gastroenterology. 141(5):1593–1604CrossRefPubMed
197.
Zurück zum Zitat Kuang FL, Alao H, Kumar S, Powers A, Quezado M, Wang Z et al (2018) Benralizumab (anti-IL5Ra) depletes gut tissue eosinophilia and improves symptoms in hypereosionphilic syndrome with gastrointestinal involvement. J Allergy Clin Immunol 141(AB):196CrossRef Kuang FL, Alao H, Kumar S, Powers A, Quezado M, Wang Z et al (2018) Benralizumab (anti-IL5Ra) depletes gut tissue eosinophilia and improves symptoms in hypereosionphilic syndrome with gastrointestinal involvement. J Allergy Clin Immunol 141(AB):196CrossRef
198.
Zurück zum Zitat Spergel JM, Rothenberg ME, Collins MH, Furuta GT, Markowitz JE, Fuchs G et al (2012) Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 129(2):456–463CrossRefPubMed Spergel JM, Rothenberg ME, Collins MH, Furuta GT, Markowitz JE, Fuchs G et al (2012) Reslizumab in children and adolescents with eosinophilic esophagitis: results of a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 129(2):456–463CrossRefPubMed
199.
Zurück zum Zitat Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Della CG et al (2001) Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 108(2):184–190CrossRefPubMed Busse W, Corren J, Lanier BQ, McAlary M, Fowler-Taylor A, Della CG et al (2001) Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 108(2):184–190CrossRefPubMed
200.
Zurück zum Zitat Bernstein JA, Kavati A, Tharp MD, Ortiz B, MacDonald K, Denhaerynck K et al (2018) Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’ evidence. Expert Opin Biol Ther 18(4):425–448CrossRefPubMed Bernstein JA, Kavati A, Tharp MD, Ortiz B, MacDonald K, Denhaerynck K et al (2018) Effectiveness of omalizumab in adolescent and adult patients with chronic idiopathic/spontaneous urticaria: a systematic review of ‘real-world’ evidence. Expert Opin Biol Ther 18(4):425–448CrossRefPubMed
201.
Zurück zum Zitat Loizou D, Enav B, Komlodi-Pasztor E, Hider P, Kim-Chang J, Noonan L et al (2015) A pilot study of omalizumab in eosinophilic esophagitis. PLoS One 10(3):e0113483CrossRefPubMedPubMedCentral Loizou D, Enav B, Komlodi-Pasztor E, Hider P, Kim-Chang J, Noonan L et al (2015) A pilot study of omalizumab in eosinophilic esophagitis. PLoS One 10(3):e0113483CrossRefPubMedPubMedCentral
202.
Zurück zum Zitat Clayton F, Fang JC, Gleich GJ, Lucendo AJ, Olalla JM, Vinson LA et al (2014) Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 147(3):602–609CrossRefPubMed Clayton F, Fang JC, Gleich GJ, Lucendo AJ, Olalla JM, Vinson LA et al (2014) Eosinophilic esophagitis in adults is associated with IgG4 and not mediated by IgE. Gastroenterology. 147(3):602–609CrossRefPubMed
203.
Zurück zum Zitat Mishra A, Rothenberg ME (2003) Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology. 125(5):1419–1427CrossRefPubMed Mishra A, Rothenberg ME (2003) Intratracheal IL-13 induces eosinophilic esophagitis by an IL-5, eotaxin-1, and STAT6-dependent mechanism. Gastroenterology. 125(5):1419–1427CrossRefPubMed
204.
Zurück zum Zitat Rothenberg ME, Wen T, Greenberg A, Alpan O, Enav B, Hirano I et al (2015) Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol 135(2):500–507CrossRefPubMed Rothenberg ME, Wen T, Greenberg A, Alpan O, Enav B, Hirano I et al (2015) Intravenous anti-IL-13 mAb QAX576 for the treatment of eosinophilic esophagitis. J Allergy Clin Immunol 135(2):500–507CrossRefPubMed
205.
Zurück zum Zitat Hirano I, Collins MH, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer AM et al (2018) RPC4046, a monoclonal antibody against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis. Gastroenterology. 156(3):592–603.e10 Hirano I, Collins MH, Assouline-Dayan Y, Evans L, Gupta S, Schoepfer AM et al (2018) RPC4046, a monoclonal antibody against IL13, Reduces Histologic and Endoscopic Activity in Patients With Eosinophilic Esophagitis. Gastroenterology. 156(3):592–603.e10
206.
Zurück zum Zitat Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson KA, Chehade M et al (2017) Dupilumab efficacy and safety in adult patients with active eosinophilic esophagitis: a randomized double-blind placebo-controlled phase 2 trial. Presented at: American College Gastroenterology National Meeting. Orlando (FL): October; 2017 Hirano I, Dellon ES, Hamilton JD, Collins MH, Peterson KA, Chehade M et al (2017) Dupilumab efficacy and safety in adult patients with active eosinophilic esophagitis: a randomized double-blind placebo-controlled phase 2 trial. Presented at: American College Gastroenterology National Meeting. Orlando (FL): October; 2017
207.
Zurück zum Zitat Berin MC, Grishin A, Masilamani M, Leung DYM, Sicherer SH, Jones SM et al (2018) Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy. J Allergy Clin Immunol 142(1):149–158.e8CrossRefPubMedPubMedCentral Berin MC, Grishin A, Masilamani M, Leung DYM, Sicherer SH, Jones SM et al (2018) Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy. J Allergy Clin Immunol 142(1):149–158.e8CrossRefPubMedPubMedCentral
208.
Zurück zum Zitat Cianferoni A, Ruffner MA, Guzek R, Guan S, Brown-Whitehorn T, Muir A et al (2018) Elevated expression of activated TH2 cells and milk-specific TH2 cells in milk-induced eosinophilic esophagitis. Ann Allergy Asthma Immunol 120(2):177–183.e2CrossRefPubMed Cianferoni A, Ruffner MA, Guzek R, Guan S, Brown-Whitehorn T, Muir A et al (2018) Elevated expression of activated TH2 cells and milk-specific TH2 cells in milk-induced eosinophilic esophagitis. Ann Allergy Asthma Immunol 120(2):177–183.e2CrossRefPubMed
209.
Zurück zum Zitat Simon D, Cianferoni A, Spergel JM, Aceves S, Holbreich M, Venter C et al (2016) Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity. Allergy. 71(5):611–620CrossRefPubMed Simon D, Cianferoni A, Spergel JM, Aceves S, Holbreich M, Venter C et al (2016) Eosinophilic esophagitis is characterized by a non-IgE-mediated food hypersensitivity. Allergy. 71(5):611–620CrossRefPubMed
210.
Zurück zum Zitat Schoepfer AM, Safroneeva E, Bussmann C, Kuchen T, Portmann S, Simon H-U et al (2013) Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology 145(6):1230–6.e1–2CrossRefPubMed Schoepfer AM, Safroneeva E, Bussmann C, Kuchen T, Portmann S, Simon H-U et al (2013) Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation in a time-dependent manner. Gastroenterology 145(6):1230–6.e1–2CrossRefPubMed
211.
Zurück zum Zitat Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N et al (2018) Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology (4):155, 1022–1033.e10 Dellon ES, Liacouras CA, Molina-Infante J, Furuta GT, Spergel JM, Zevit N et al (2018) Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. Gastroenterology (4):155, 1022–1033.e10
212.
Zurück zum Zitat Ruffner MA, Capucilli P, Hill DA, Spergel JM (2019 Feb) Screening children for eosinophilic esophagitis: allergic and other risk factors. Expert Rev Clin Immunol 5:1–4 Ruffner MA, Capucilli P, Hill DA, Spergel JM (2019 Feb) Screening children for eosinophilic esophagitis: allergic and other risk factors. Expert Rev Clin Immunol 5:1–4
Metadaten
Titel
Allergic Comorbidity in Eosinophilic Esophagitis: Mechanistic Relevance and Clinical Implications
verfasst von
Peter Capucilli
David A. Hill
Publikationsdatum
22.03.2019
Verlag
Springer US
Erschienen in
Clinical Reviews in Allergy & Immunology / Ausgabe 1/2019
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI
https://doi.org/10.1007/s12016-019-08733-0

Weitere Artikel der Ausgabe 1/2019

Clinical Reviews in Allergy & Immunology 1/2019 Zur Ausgabe

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.